Floatz logo

BLOOD, WHOLE

Genetic Predisposition to Disease

University Hospital, Lilleother_biologicalDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Genetic Predisposition to Disease cohort.

Asset / SponsorPhaseRating
Cephalexin
University of California, San Francisco
Phase 2CCC
Aln-Pnp
Regeneron Pharmaceuticals
Phase 1CC
Minoxidil
Duke University
Phase 1CC
Fluconazole
Bochud Pierre-Yves
N/AD
Posaconazole
Bochud Pierre-Yves
N/AD

Same molecule, other indications

BLOOD, WHOLE is also rated in:

hepatic encephalopathyDormant
BB
Indicative ·
64 / 100
View asset →
cirrhosis of liverDormant
B
Indicative ·
61 / 100
View asset →
Shock HypovolemicDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →